Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × toripalimab × Clear all

NCT06221774 2024-01-24

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Phase 1/2 Unknown

Carcinoma, Renal Cell, Carcinoma, Transitional Cell